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Antibioticmode-of-actionclassification isbased
upon drug-target interaction and whether the
resultant inhibition of cellular function is lethal
to bacteria. Here we show that the three major
classes of bactericidal antibiotics, regardless
of drug-target interaction, stimulate the produc-
tion of highly deleterious hydroxyl radicals in
Gram-negative and Gram-positive bacteria,
which ultimately contribute to cell death. We
also show, in contrast, that bacteriostatic drugs
do not produce hydroxyl radicals. We demon-
strate that the mechanism of hydroxyl radical
formation induced by bactericidal antibiotics is
the end product of an oxidative damage cellular
death pathway involving the tricarboxylic acid
cycle, a transient depletion of NADH, destabili-
zation of iron-sulfur clusters, and stimulation
of the Fenton reaction. Our results suggest that
all three major classes of bactericidal drugs can
be potentiated by targeting bacterial systems
that remediate hydroxyl radical damage, includ-
ing proteins involved in triggering the DNA
damage response, e.g., RecA.
INTRODUCTION
Current antimicrobial therapies, which cover a wide array
of targets (Walsh, 2003), fall into two general categories:
bactericidal drugs, which kill bacteria with an efficiency
of >99.9%, and bacteriostatic drugs, which merely inhibit
growth (Pankey and Sabath, 2004). Antibacterial drug-
target interactions are well studied and predominantly
fall into three classes: inhibition of DNA replication and
repair, inhibition of protein synthesis, and inhibition of
cell-wall turnover (Walsh, 2000). The bactericidal antibiotickilling mechanisms are currently attributed to the class-
specific drug-target interactions. However, our under-
standing of many of the bacterial responses that occur
as a consequence of the primary drug-target interaction
remains incomplete (Davis, 1987; Drlica and Zhao, 1997;
Lewis, 2000; Tomasz, 1979).
Bacteriostatic drugs predominantly inhibit ribosome
function, targeting both the 30S (tetracycline family and
aminocyclitol family) and 50S (macrolide family and chlor-
amphenicol) ribosome subunits (Chopra and Roberts,
2001; Poehlsgaard and Douthwaite, 2005; Tenson et al.,
2003; Weisblum and Davies, 1968). The aminocyclitol
group of 30S inhibitors includes the bactericidal aminogly-
coside family of drugs and the bacteriostatic drug specti-
nomycin; the aminoglycoside family, excluding spectino-
mycin, is the only class of ribosome inhibitors known to
cause protein mistranslation (Davis, 1987; Weisblum and
Davies, 1968). With regard to other classes of bactericidal
antibiotics, quinolones target DNA replication and repair
by bindingDNA gyrase complexedwith DNA, which drives
double-strand DNA break formation and cell death (Drlica
and Zhao, 1997). Cell-wall synthesis inhibitors (such as b-
lactams), which interact with penicillin-binding proteins
(Tomasz, 1979) and glycopeptides that interact with pep-
tidoglycan building blocks (Reynolds, 1989), interfere with
normal cell-wall synthesis and induce lysis and cell death.
With the alarming spread of antibiotic-resistant strains of
bacteria (Walsh, 2000, 2003), a better understanding of
the specific sequence of events leading to cell death
from the wide range of bactericidal antibiotics is needed
for future antibacterial drug advancement.
We have recently shown that bacterial gyrase inhibitors,
including synthetic quinolone antibiotics and the native
proteic toxin CcdB, induce a breakdown in iron regulatory
dynamics, which promotes formation of reactive oxygen
species that contribute to cell death (Dwyer et al., 2007).
Hydroxyl radical formation utilizing internal iron and the
Fenton reaction appears to be the most significant con-
tributor to cell death among the reactive oxygen species
formed. The Fenton reaction leads to the formation ofCell 130, 797–810, September 7, 2007 ª2007 Elsevier Inc. 797
hydroxyl radicals through the reduction of hydrogen
peroxide by ferrous iron (Imlay et al., 1988; Imlay and
Linn, 1986). We chose to investigate whether hydroxyl
radical formation also contributes to antibiotic-induced
cell death in bacteria among the other classes of antibi-
otics. Here we report that the three major classes of bac-
tericidal antibiotics, regardless of drug-target interaction,
stimulate hydroxyl radical formation in bacteria. Further-
more, we demonstrate that hydroxyl radical generation
contributes to the killing efficiency of these lethal drugs.
We also show, in contrast, that bacteriostatic drugs do
not produce hydroxyl radicals. We demonstrate that all
bactericidal drug classes utilize internal iron from iron-
sulfur clusters to promote Fenton-mediated hydroxyl
radical formation and show that these events appear to
be mediated by the tricarboxylic acid (TCA) cycle and
a transient depletion of NADH. We propose that there is
a common mechanism of cellular death underlying all
classes of bactericidal antibiotics whereby harmful
hydroxyl radicals are formed as a function of metabo-
lism-related NADH depletion, leaching of iron from iron-
sulfur clusters, and stimulation of the Fenton reaction.
RESULTS
Bactericidal Antibiotics Induce Hydroxyl Radical
Formation
Using the dye hydroxyphenyl fluorescein (HPF), which is
oxidized by hydroxyl radicals with high specificity (Setsu-
kinai et al., 2003), we first examined a concentration of
hydrogen peroxide known to induce hydroxyl radical
formation via Fenton chemistry (Imlay et al., 1988). As
expected (Imlay et al., 1988), we observed cellular death
with 1 mM hydrogen peroxide (Figure 1A) accompanied
by an increase in HPF fluorescence (Figure 1B). Addition-
ally, we confirmed dye specificity for hydroxyl radicals by
inhibiting the Fenton reaction and hydroxyl radical forma-
tion with the iron chelator 2,20-dipyridyl and by directly
quenching Fenton-generated hydroxyl radicals with the
hydroxyl radical scavenger thiourea (Figures 1A and 1B).
Application of iron chelators is an established means of
blocking Fenton reaction-mediated hydroxyl radical for-
mation by sequestering unbound iron (Imlay et al., 1988).
Thiourea is a potent hydroxyl radical scavenger that is
an established means of mitigating the effects of hydroxyl
radical damage in both eukaryotes and prokaryotes (No-
vogrodsky et al., 1982; Repine et al., 1981; Touati et al.,
1995). In this manner, we showed that HPF fluorescence
is a reliable measure of hydroxyl radical formation in
bacteria.
We next investigated hydroxyl radical formation follow-
ing exposure to the three major classes of bactericidal
antibiotics in Escherichia coli (E. coli) (Figures 1C and
1D). Specifically, we examined killing by the quinolone
(250 ng/ml norfloxacin), b-lactam (5 mg/ml ampicillin),
and aminoglycoside (5 mg/ml kanamycin) classes. We
found that each of the three different classes of bacteri-798 Cell 130, 797–810, September 7, 2007 ª2007 Elsevier Inc.cidal antibiotics induced hydroxyl radical formation
(Figure 1D); norfloxacin and ampicillin induced hydroxyl
radical formation within 1 hr and kanamycin by 2 hr after
addition of drug (see Figure S1 in the Supplemental Data
available with this article online). In contrast, the five
bacteriostatic drugs we tested (Figure 1E), including four
different classes of ribosome inhibitors (chloramphenicol,
spectinomycin, tetracycline, and the macrolide erythro-
mycin) as well as an inhibitor of RNA polymerase (rifamy-
cin SV, referred to as rifamycin; Wehrli and Staehelin
[1971]), did not stimulate hydroxyl radical production
(Figure 1F and Figure S2D).
Interestingly, in ampicillin-treated cultures, we
observed a bimodal distribution of hydroxyl radical pro-
duction at 2 and 3 hr post drug application (Figure 1D
and Figure S1C) that correlated with the onset of cell lysis
(Figure S8A); the decline in the number of cells producing
radicals between 2 and 3 hr is consistent with the ongoing
cell lysis. In contrast, prior to lysis (1 hr posttreatment),
ampicillin application yielded a uniform increase in
hydroxyl radical formation (Figures S1C and S8A). These
results suggest a role for hydroxyl radicals in both the
lethal and lytic effects of b-lactams.
We sought to demonstrate that Gram-positive, as well
as Gram-negative, bacteria produce hydroxyl radicals in
response to bactericidal antibiotics. We examined
hydroxyl radical production for a bacteriostatic drug
(chloramphenicol), a bactericidal drug (norfloxacin), and
both lethal (5 mg/ml) and sublethal (1 mg/ml) concentra-
tions of vancomycin (a Gram-positive specific bactericidal
drug; Reynolds [1989]) in a wild-type strain of Staphylo-
coccus aureus (S. aureus) (Figure S3A). We observed an
increase in hydroxyl radical production for the norfloxacin
treatment and for the lethal concentration of vancomycin
(Figure S3). Conversely, we did not observe hydroxyl rad-
ical production for the chloramphenicol treatment or the
sublethal concentration of vancomycin, the latter of which
had no effect on growth (Figure S3). Cumulatively, our
hydroxyl radical results suggest that the genetic and
biochemical changes that arise following application of le-
thal doses of bactericidal antibiotics create an intracellular
environment that promotes the formation of highly delete-
rious oxidative radical species.
Hydroxyl Radical Formation for All Bactericidal
Classes Involves the Fenton Reaction
and Intracellular Iron
To demonstrate that hydroxyl radical formation is an
important component of norfloxacin-, ampicillin-, and
kanamycin-mediated killing, we additionally treated
drug-exposed wild-type E. coli with the iron chelator
2,20-dipyridyl. For the three classes of bactericidal drug
treatments, we observed a significant increase in bacterial
survival following addition of 2,20-dipyridyl (Figures 2A,
2C, and 2E), confirming that hydroxyl radicals are involved
in bactericidal antibiotic-induced cell death. 2,20-dipyridyl
significantly reduced hydroxyl radical formation in norflox-
acin-treated cultures (Figure 2B), and there appeared to
Figure 1. Hydroxyl Radical Production in E. coli by Hydrogen Peroxide and Antibiotics
(A, C, and E) Log change in colony-forming units permilliliter (cfu/ml). Black squares represent a no-drug control. In this and all other figures, error bars
represent ±SD of the mean.
(B, D, and F) Generation of hydroxyl radicals. Representativemeasurements are shown andwere taken 3 hr following addition of drug. Gray diamonds
represent time-zero baseline measurements.
(A and B) Survival (A) and hydroxyl radical formation (B) following 1 mM H2O2 treatment alone (green), plus 150 mM thiourea (red), or plus 500 mM 2,
20-dipyridyl (blue).
(C and D) Survival (C) and hydroxyl radical generation (D) following exposure to bactericidal antibiotics (5 mg/ml ampicillin [Amp], blue; 5 mg/ml kana-
mycin [Kan], green; 250 ng/ml norfloxacin [Nor], red).
(E and F) Survival (E) and hydroxyl radical generation (F) following exposure to bacteriostatic drugs (600 mg/ml erythromycin [Eryth], light blue;
400 mg/ml spectinomycin [Spect], yellow; 15 mg/ml chloramphenicol [Cam], pink; 10 mg/ml tetracycline [Tet], blue; 500 mg/ml rifamycin [Rif], red).be some recovery from the norfloxacin-induced growth
arrest and DNA damage between 2 and 3 hr into the
treatment in the presence of 2,20-dipyridyl (Figure 2A).
Similarly, killing by ampicillin and kanamycin was reduced
to less than 0.5 logs following application of the iron
chelator (Figures 2C and 2E) and was accompanied by
a significant reduction in hydroxyl radical formation (Fig-
ures 2D and 2F). As expected, addition of the iron chelator
to bacteriostatic drug-treated cultures, which do not pro-
duce hydroxyl radicals, had no effect on the growth-
arresting properties of these bacteriostatic classes of
drugs (Figure S4A).CWe next sought to directly block the harmful effects of
hydroxyl radicals generated via the Fenton reaction by
adding thiourea to drug-treated cultures. We found that
cultures treated with norfloxacin and thiourea showed
a significant delay in cell death at 1 hr and a near 1-log
increase in survival at 3 hr relative to norfloxacin treatment
alone (Figure 2A). This increase in survival again correlated
with a decrease in the detectable levels of hydroxyl radi-
cals (Figure 2B). Thiourea was able to reduce ampicillin-
mediated killing (Figure 2C) and hydroxyl radical formation
(Figure 2D) to the same extent that 2,20-dipyridyl was.
Thiourea was less efficient at mitigating bacterial cellell 130, 797–810, September 7, 2007 ª2007 Elsevier Inc. 799
Figure 2. Effect of Iron Chelation, Hydroxyl Radical Quenching, and Disabling of Iron-Sulfur Cluster Synthesis on the Killing
Efficiency of Bactericidal Antibiotics
(A, C, and E) Log change in cfu/ml following exposure to 250 ng/ml Nor (A), 5 mg/ml Amp (C), or 5 mg/ml Kan (E). Changes in cfu/ml following addition of
500 mM 2,20-dipyidyl (blue diamonds) or 150 mM thiourea (red diamonds) to wild-type (WT) E. coli and an iron-sulfur cluster synthesis mutant, DiscS
(yellow diamonds), are shown. In each panel, black squares represent a no-drug control and green diamonds represent wild-type E. coli exposed to
drug alone.
(B, D, and F) Generation of hydroxyl radicals following exposure to 250 ng/ml Nor (B), 5 mg/ml Amp (D), or 5 mg/ml Kan (F). Representative measure-
ments are shown and were taken 3 hr following addition of drug. The gray line represents time-zero baseline measurements, and the green line rep-
resents wild-type E. coli exposed to drug alone. Changes in hydroxyl radical formation following addition of 500 mM2,20-dipyidyl (blue line) or 150mM
thiourea (red line) to wild-type E. coli and an iron-sulfur cluster synthesis mutant, DiscS (yellow line), are shown.death following kanamycin treatment (Figure 2E), which
was reflected by the capacity of thiourea to reduce, but
not eliminate, kanamycin-mediated hydroxyl radical for-
mation (Figure 2F); this requires further investigation.
Addition of the radical quencher to bacteriostatic drug-
treated cultures had minimal effects on the growth-arrest-
ing properties of these bacteriostatic classes of drugs
(Figure S4B).800 Cell 130, 797–810, September 7, 2007 ª2007 Elsevier Inc.Our results with 2,20-dipyridyl and thiourea indicate that
hydroxyl radical formation and the Fenton reaction play
a critical role in effective killing by quinolones, b-lactams,
and aminoglycosides. The ferrous iron required for hy-
droxyl radical formation could come from extracellular
sources, such as iron import, or from intracellular sources,
such as iron storage proteins or iron-sulfur clusters. To
determine whether disabling iron import would reduce
bactericidal drug lethality, we examined the efficacy of
bactericidal antibiotics in a DtonB strain. TonB is a re-
quired protein in the energy-dependent step of iron trans-
port across the inner membrane of E. coli (Moeck and
Coulton, 1998), and a tonB knockout has previously
been shown to have a protective effect following exposure
to oxidant stress exogenously induced via application of
hydrogen peroxide (Touati et al., 1995). Our data show
that removal of tonB provided no protective effect against
norfloxacin-, kanamycin-, or ampicillin-mediated killing
(Figure S5). This suggests that the import of external iron
does not play a significant role in effecting killing by bac-
tericidal drugs.
To determine whether oxidative damage of iron-sulfur
clusters is a key source of ferrous iron driving hydroxyl
radical formation for bactericidal drugs, we examined
the killing properties of the bactericidal drugs in a DiscS
strain; the iscS knockout has been shown to significantly
impair iron-sulfur cluster synthesis capabilities and result
in a decrease in iron-sulfur cluster abundance (Djaman
et al., 2004; Schwartz et al., 2000). In this strain, we ob-
served a significant reduction in cell death following treat-
ment with norfloxacin (Figure 2A), ampicillin (Figure 2C), or
kanamycin (Figure 2E). We found that the protective effect
ofDiscS is related to a reduction in hydroxyl radical forma-
tion following treatment with norfloxacin (Figure 2B), ampi-
cillin (Figure 2D), or kanamycin (Figure 2F). These results
imply that intracellular ferrous iron is a key source for Fen-
ton-mediated hydroxyl radical formation by bactericidal
drugs.
Catabolic NADH Depletion Is the Trigger for
Hydroxyl Radical Formation
It is interesting to consider how functionally distinct bacte-
ricidal drugs commonly stimulate damage to iron-sulfur
clusters. The established mechanism underlying leaching
of iron from iron-sulfur clusters predominantly occurs via
superoxide (Imlay, 2006; Keyer and Imlay, 1996; Liochev
and Fridovich, 1999), and it is well accepted that the ma-
jority of superoxide generation in E. coli occurs through
oxidation of the respiratory electron transport chain driven
by oxygen and the conversion of NADH to NAD+ (Imlay
and Fridovich, 1991). We utilized gene expression micro-
arrays and statistical analyses (see Experimental Proce-
dures) to find sets of genes commonly upregulated or
downregulated by the bactericidal drugs norfloxacin, am-
picillin, and kanamycin relative to the bacteriostatic drug
spectinomycin (Table 1). Interestingly, pathway enrich-
ment (q value < 0.05) using Gene Ontology (Ashburner
et al., 2000; Camon et al., 2004) found NADH-coupled
electron transport (NADH dehydrogenase I) to be a key
upregulated pathway common to all three bactericidal
drug classes (Table 1).
We used a modified version (Leonardo et al., 1996) of
the NAD+ cycling assay developed by Bernofsky and
Swan (1973) to monitor NAD+ and NADH concentrations
in wild-type E. coli following treatment with norfloxacin,
ampicillin, and kanamycin (Figure 3A). For all three bacte-Cricidal drugs, we observed a >5-fold increase in the NAD+/
NADH ratio 0.5 hr after drug addition (Figure 3A). This ratio
returned to untreated levels by 1 hr (Figure 3A). The in-
crease in the NAD+/NADH ratio was predominantly due
to a large relative drop in NADHaccompanied by amodest
surge in NAD+. This spike was not observed in an un-
treated culture, where the NAD+/NADH ratio remained
tightly bounded (Figure 3A). More importantly, treatment
with the bacteriostatic drug spectinomycin had no effect
on the NAD+/NADH ratio relative to the untreated culture
(Figure 3A). A surge in NADH consumption upon exposure
to bactericidal antibiotics likely induces a burst in super-
oxide generation via the respiratory chain. Accordingly,
these events may promote destabilization of iron-sulfur
clusters, stimulation of the Fenton reaction, and cell death.
NADH is generated from NAD+ during the TCA cycle
(Cronan and Laporte, 2006). Therefore, loss of TCA-cycle
component genes should reduce the available pool of
NADH, decrease superoxide generation, and lead to in-
creased survival following exposure to bactericidal drugs.
Since NADH is produced at different points along the TCA
cycle, the increase in survival should follow a gradient rel-
ative to the number of NADHmolecules produced. Loss of
genes before production of the first reduced dinucleotide
(e.g., aconitase B [acnB] or isocitrate dehydrogenase
[icdA]) should lead to larger increases in survival than
loss of genes after the various NADH-producing steps in
the TCA cycle (e.g., 2-ketoglutarate dehydrogenase
[sucB, sucA, lpdA] or malate dehydrogenase [mdh])
(Figure 3B). We found that blocking the TCA cycle before
the formation of the first reduced dinucleotide (DicdA and
DacnB) led to increased survival following norfloxacin
treatment, which had the largest increase in NAD+/
NADH ratio, whereas TCA-cycle knockouts after this point
(DsucB and Dmdh) behaved like wild-type (Figure 3C).
Blocking the TCA cycle through to the second NADH for-
mation step (DacnB, DicdA, and DsucB) led to increased
survival following ampicillin treatment, while blocking the
last NADH formation step (Dmdh) did not affect survival
(Figure 3D). Finally, each of the TCA-cycle knockout
strains (DacnB, DicdA, DsucB, and Dmdh) exhibited in-
creased survival following exposure to kanamycin
(Figure 3E).
It is important to note that aconitase A (AcnA) and aco-
nitase B are the two main forms of aconitase in E. coli:
AcnB functions as the main catabolic enzyme in the TCA
cycle, while AcnA responds to oxidative stress (Cunning-
ham et al., 1997). As expected, for all three classes of bac-
tericidal drugs, we observed increased survival only with
DacnB; DacnA behaved like wild-type (Figures 3C–3E). In-
terestingly, one of the first mutants selected for resistance
to low levels of nalidixic acid, a quinolone, was mapped to
a loss of isocitrate dehydrogenase (icdA) (Helling and Ku-
kora, 1971), while later studies found that removing both
acnA and acnB similarly conferred resistance (Gruer
et al., 1997). The surge in NADH consumption induced
by bactericidal drugs, coupled with the phenotypic results
from the TCA-cycle knockouts, all point toward efficientell 130, 797–810, September 7, 2007 ª2007 Elsevier Inc. 801
Table 1. Common Set of Differentially Expressed
Genes for Bactericidal Antibiotics
Gene Function
Upregulated (38)
apaG protein associated with Co2+
and Mg2+ efflux
arsC arsenate reductase, drug/analog
sensitivity
asnA asparagine synthetase
b3275 23S ribosomal RNA of rrnD operon
cpxP periplasmic protein combats stress,
periplasmic repressor of cpx regulon
by interaction with CpxA
dipZ fused thiol:disulfide interchange
protein, activator of DsbC
dnaK chaperone Hsp70, cochaperone
with DnaJ
groL Cpn60 chaperonin GroEL, large
subunit of GroESL
groS Cpn10 chaperonin GroES, small
subunit of GroESL
hdfR transcriptional regulator of the flhDC
operon
hslU molecular chaperone and ATPase
component of HslUV protease
murF UDP-N-acetylmuramoyl-
tripeptide:D-alanyl-D-alanine ligase
nuoCa NADH:ubiquinone oxidoreductase,
NADH dehydrogenase I chain C,D
nuoEa NADH dehydrogenase subunit E,
catalyzes the transfer of electrons
from NADH to ubiquinone
nuoFa NADH:ubiquinone oxidoreductase,
NADH dehydrogenase I chain F
pdxA NAD-dependent 4-hydroxy-L-
threonine phosphate dehydrogenase
pepD aminoacyl-histidine dipeptidase
(peptidase D)
phnD phosphonate/organophosphate ester
transporter subunit
phoU negative regulator of PhoR/PhoB
two-component system, negative
regulator for pho regulon and putative
enzyme in phosphate metabolism
ppk polyphosphate kinase, component
of RNA degradosome
pstB ATP-binding component of high-
affinity phosphate-specific transport
system
ptsA PEP-protein phosphotransferase
system enzyme I802 Cell 130, 797–810, September 7, 2007 ª2007 Elsevier Inc.Table 1. Continued
Gene Function
ptsP mannose-specific enzyme IIC
component of PTS
rrsC 16S ribosomal RNA of rrnC operon
rrsG 16S ribosomal RNA of rrnG operon
rrsH 16S ribosomal RNA of rrnH operon
sbcD ATP-dependent dsDNA exonuclease
tnaB low-affinity tryptophan permease
xerC site-specific tyrosine recombinase,
affects chromosome segregation
at cell division
ybeY hypothetical protein
ybjH hypothetical protein
ygdH hypothetical protein
ygiB conserved outer membrane protein
yhcM conserved protein with nucleoside
triphosphate hydrolase domain
yihQ putative glycosidase
yihT putative aldolase
yijO predicted DNA-binding
transcriptional regulator
yjbE hypothetical protein
Downregulated (142)
ade purine ribonucleotide biosynthesis
aroM protein of aro operon, regulated
by aroR
b1229 predicted protamine-like protein
b1231 tRNA-Tyr
b2087 pseudogene, repressor for gat
operon
bacA putative transport, drug/analog
sensitivity
blr beta-lactam resistance membrane
protein
cdd salvage of nucleosides and
nucleotides, cytidine deaminase
cdsA fatty acid and phosphatidic acid
biosynthesis
chpR antitoxin of the ChpA-ChpR toxin-
antitoxin system
cmr proton motive force efflux pump
cobU adenosylcobinamide kinase/
adenosylcobinamide-phosphate
guanylyltransferase
csdA cysteine sulfinate desulfinase
cspF Qin prophage, cold-shock protein
Table 1. Continued
Gene Function
dapE succinyl-diaminopimelate
desuccinylase
dusC tRNA-dihydrouridine synthase C
exo DNA exonuclease IX, 30-
phosphodiesterase activity at sites
with 30 incised apurinic/apyrimidinic
sites, can remove 30
phosphoglycolate groups
fruA fructose-specific transport protein
fruB fructose-specific IIA/fpr component
fruK 1-phosphofructokinase
gcvA DNA-binding transcriptional dual
regulator, positive regulator of gcv
operon
gltS glutamate transporter
gntK gluconate kinase 2, gluconokinase 2
gntT gluconate transporter, gluconate
permease
gntU gluconate transporter, low-affinity
GNT 1 system
gpmB phosphoglycerate mutase
idnK D-gluconate kinase
insJ IS150 protein InsA, transposon-
related functions
insN-2 KpLE2 phage-like element,
transposon-related functions
intB KpLE2 phage-like element, predicted
integrase
ispU undecaprenyl pyrophosphate
synthase
lpxC UDP-3-O-acyl N-acetylglucosamine
deacetylase
lpxL lauryl-acyl carrier protein-dependent
acyltransferase
lsrR lsr operon transcriptional repressor
maa maltose O-acetyltransferase
mdtI multidrug efflux system transporter,
possible chaperone
metN DL-methionine transporter subunit
mltA membrane-bound lytic murein
transglycosylase A
molR pseudogene molybdate metabolism
regulator
nanA N-acetylneuraminate lyase
norR anaerobic nitric oxide reductase
transcription regulator, required
for the expression of anaerobic
nitric oxide reductaseTable 1. Continued
Gene Function
nudE ADP-ribose diphosphatase
obgE GTPase involved in cell partioning
and DNA repair
pabC 4-amino-4-deoxychorismate lyase
priC primosomal replication protein N00
puuA putative glutamine synthetase
puuD gamma-Glu-GABA hydrolase
puuR DNA-binding transcriptional repressor
rdlA antisense RNA, trans-acting regulator
of ldrA translation
relB bifunctional antitoxin of the RelE-RelB
toxin-antitoxin system,
transcriptional repressor
relE toxin of the RelE-RelB toxin-antitoxin
system
rem predicted protein
renD DLP12 prophage, predicted protein
rluC 23S rRNA pseudouridylate synthase
rpiB ribose-5-phosphate isomerase B
rttR rtT sRNA, processed from tyrT
transcript, may modulate the
stringent response
rumB RNA uridine methyltransferase B
ruvB Holliday junction DNA helicase B
rygC sRNA, function unknown
sanA transport, drug/analog sensitivity
sieB Rac prophage
sirA small protein required for cell growth,
affects RpoS stability
tadA tRNA-specific adenosine deaminase
torR DNA-binding response regulator in
two-component regulatory system
with TorS
tyrP tyrosine-specific transport system
yadR hypothetical protein
yagI predicted DNA-binding
transcriptional regulator
yahA predicted DNA-binding
transcriptional regulator
ybcW hypothetical protein
ybcY predicted SAM-dependent
methyltransferase
ybdH predicted oxidoreductase
ybiN predicted SAM-dependent
methyltransferase
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Table 1. Continued
Gene Function
ycbW hypothetical protein
ycdC predicted DNA-binding
transcriptional regulator
ycdP predicted inner membrane protein
ycdT predicted diguanylate cyclase
ycdZ predicted inner membrane protein
yceG predicted aminodeoxychorismate
lyase, putative thymidylate kinase
ycjM predicted glucosyltransferase,
putative polysaccharide hydrolase
ydgC conserved inner membrane protein
associated with alginate
biosynthesis
ydgK conserved inner membrane protein
ydhI predicted inner membrane protein
ydjE predicted transporter
ydjF putative DEOR-type transcriptional
regulator
ydjL predicted oxidoreductase,
Zn-dependent and NAD(P)-binding
ydjM predicted inner membrane protein
regulated by LexA
yeaS neutral amino-acid efflux system
yebN conserved inner membrane protein
yecF hypothetical protein
yedV putative two-component sensor
protein
yegJ hypothetical protein
yegQ predicted peptidase
yegW predicted DNA-binding
transcriptional regulator
yegZ pseudogene, gpD phage P2-like
protein D
yeiS predicted inner membrane protein
yejG hypothetical protein
yfaZ predicted outer membrane porin
protein
yfbP hypothetical protein
yfbV hypothetical protein
yfeS hypothetical protein
yfeU N-acetylmuramic acid-6-phosphate
etherase
yfeY hypothetical protein
yfeZ predicted inner membrane protein
yfgO putative permease804 Cell 130, 797–810, September 7, 2007 ª2007 Elsevier Inc.Table 1. Continued
Gene Function
yfhL predicted 4Fe-4S cluster-containing
protein
yfiF predicted methyltransferase
ygdL hypothetical protein
ygeP hypothetical protein
ygeQ hypothetical protein
yggN hypothetical protein
ygiT predicted DNA-binding
transcriptional regulator
ygjM predicted DNA-binding
transcriptional regulator
ygjN hypothetical protein
yhaM hypothetical protein
yhaO putative transport system permease
protein
yhbE conserved inner membrane protein
yhbP hypothetical protein
yhdL hypothetical protein
yhjQ cell division protein (chromosome-
partitioning ATPase) pseudogene
yiiX predicted peptidoglycan peptidase
yjaA hypothetical protein
yjaH hypothetical protein
yjeJ hypothetical protein
yjeM predicted transporter
yjeO conserved inner membrane protein
yjhB putative transport protein
yjhC predicted oxidoreductase, putative
dehydrogenase
yjhE predicted membrane protein
(pseudogene)
yjhI predicted DNA-binding
transcriptional regulator
yjhP putative methyltransferase
yjhQ predicted acetyltransferase
yjhX hypothetical protein
ykiA hypothetical protein
ymcD hypothetical protein
ynaK hypothetical protein
ynbB predicted CDP-diglyceride synthase,
putative phosphatidate
cytidyltransferase
ynjI predicted inner membrane protein
yohL hypothetical protein
metabolism as an important aspect of killing by bacteri-
cidal drugs. This also suggests a mechanistic basis for
the observation that carbon source limitation reduces
the efficacy of killing by bactericidal drugs (Eng et al.,
1991). Together, these results indicate that bactericidal
drugs, for all of their diverse targets, stimulate hydroxyl
radical formation through a common pathway.
Table 1. Continued
Gene Function
ypeA putative acetyltransferase
yraQ predicted permease
yrhB hypothetical protein
ytfA predicted transcriptional regulator
a Pathway enrichment using Gene Ontology identified NADH-
coupled electron transport (false discovery rate = 0.0345) as
the only upregulated pathway common to all three bacteri-
cidal drug classes.CAll Bactericidal Drugs Induce DNA and Protein
Damage
Hydroxyl radicals are extremely toxic and will readily
damage proteins, membrane lipids, and DNA (Farr and
Kogoma, 1991). Following application of bactericidal
antibiotics, we would expect to see initiation of the DNA
damage response system (SOS response), where RecA
is activated by DNA damage, promoting autocleavage of
the LexA repressor protein and stimulation of SOS
response genes (Courcelle andHanawalt, 2003; Friedberg
et al., 2005). To examine SOS induction by the various
bactericidal and bacteriostatic drugs used, we employed
an engineered promoter-reporter gene construct that
expresses green fluorescent protein (GFP) upon LexA
autocleavage.
As expected, we observed a significant increase in SOS
activity upon treatment with norfloxacin (Figure 4). b-lac-
tams have recently been shown to induce expression of
the SOS responsemediator of filamentation, sulA, through
the DpiBA two-component system (Miller et al., 2004).Figure 3. Role of the Tricarboxylic Acid Cycle and NAD+/NADH in Bactericidal Antibiotic-Induced Cell Death
(A) Fold change in NAD+/NADH (nmol/ml) following treatment with 250 ng/ml Nor (red triangles), 5 mg/ml Amp (blue circles), 5 mg/ml Kan (green di-
amonds), 400mg/ml Spect (gray squares), or no drug (black squares, dashed line). NAD+ andNADHwere below the detection limit between 2 and 3 hr
after the addition of ampicillin.
(B) Predicted increase in survival for tricarboxylic acid (TCA) cycle gene knockouts exposed to bactericidal drugs.
(C–E) Log change in cfu/ml. Survival of wild-type E. coli (black circles, dashed line), DicdA (red triangles), DacnA (green triangles), DacnB (blue
triangles), DsucB (purple triangles), and Dmdh (orange triangles) following treatment with 250 ng/ml Nor (C), 5 mg/ml Amp (D), and 5 mg/ml Kan (E).ell 130, 797–810, September 7, 2007 ª2007 Elsevier Inc. 805
LexA-driven GFP expression showed that ampicillin
induced the SOS response via RecA activation (Figure 4),
and the bimodal distribution is consistent with the
observed bimodal distribution of hydroxyl radical forma-
tion following ampicillin treatment (Figure 1D). Following
kanamycin treatment, we did not see any change in SOS
activity over the course of the experiment (Figure 4). Since
our reporter construct requires active transcription and
translation to express GFP upon LexA autocleavage and
kanamycin blocks translation, these data (Figure 4) do
not rule out oxidative DNA damage following kanamycin
treatment, particularly given our hydroxyl radical data
(Figure 1D) and the damage that these oxidative radicals
can cause to DNA.
Our results concerning hydroxyl radical formation
(Figure 1D) provide amechanistic basis for the earlier find-
ings that the killing effects of quinolones (Lewin et al.,
1989) and b-lactams (Miller et al., 2004) can be potentiated
by knocking out recA and disabling the SOS response,
which we confirmed as shown in Figure 5. To demonstrate
that disabling the SOS response can also increase the
potency of aminoglycosides, we examined kanamycin’s
killing efficiency in a recA knockout. We observed, in the
DrecA strain compared to wild-type, a significant increase
in cell death following addition of kanamycin (Figure 5).
The increased sensitivity of the DrecA strain highlights
the importance of an intact DNA damage repair system
for mitigating the effects of hydroxyl radical-mediated
DNA damage induced by all three major classes of bacte-
ricidal antibiotics (see Supplemental Data for results with
bacteriostatic drugs). The increased sensitivity is most
evident following norfloxacin treatment, where the primary
DNA-damaging properties of quinolones are amplified by
hydroxyl radical-mediated damage to DNA.
As noted above, hydroxyl radicals will also damage pro-
teins and membrane lipids in addition to DNA. In our gene
expression analysis comparing bactericidal to bacterio-
Figure 4. SOS Induction in E. coli by Bactericidal Antibiotics
Activation of the SOS (DNA damage) responsewasmonitored using an
engineered sensor construct that employs the LexA repressor for con-
trol of green fluorescent protein (GFP) expression. Representative GFP
histogram measurements taken 3 hr after addition of bactericidal anti-
biotics (25 ng/ml Nor, red line; 5 mg/ml Amp, blue line; 5 mg/ml Kan,
green line) are shown.806 Cell 130, 797–810, September 7, 2007 ª2007 Elsevier Inc.static antibiotic treatment (Table 1), we see significant
upregulation of genes involved in the regulation of
misfolded proteins (hslU, dnaK, groL, groS) as well as
a negative regulator of a key stress-response system
(cpxP) (Danese and Silhavy, 1998). This result is expected
in the context of aminoglycosides, as protein mistransla-
tion is one of the phenotypes separating aminoglycosides
from bacteriostatic ribosome inhibitors (Davis, 1987;
Weisblum and Davies, 1968). However, we see this
response for all bactericidal drugs, including the DNA-
damaging quinolones and cell-wall synthesis-inhibiting
b-lactams. This suggests that in addition to hydroxyl
radical-mediated DNA damage, there is enough hydroxyl
radical-mediated protein damage to require activation of
chaperone systems.
In addition to heat-shock genes, there are a number of
genes involved in cell-wall and outer membrane turnover
that are significantly upregulated (pepD,murF) or downre-
gulated (dapE, lpxC, lpxL, bacA, ispU) by all three bacteri-
cidal antibiotics (Table 1). Gene expression changes
among these cell envelope systems have been observed
following oxidative damage with paraquat (Pomposiello
et al., 2001). Further discussion of our gene expression
analysis is provided in the Supplemental Data.
DISCUSSION
In this study, we have shown that the three major classes
of bactericidal drugs all utilize a common mechanism of
killing whereby they stimulate the production of lethal
doses of hydroxyl radicals (Figure 6). We demonstrated
through application of an iron chelator that quinolones,
Figure 5. Potentiation of Bactericidal Antibiotics in DrecA
E. coli
Log change in cfu/ml of DrecA E. coli following exposure to 25 ng/ml
Nor (orange triangles), 2 mg/ml Amp (purple circles), and 3 mg/ml Kan
(cyan diamonds). For comparison, cfu/ml are also shown for wild-
type E. coli exposed to 25 ng/ml Nor (red triangles), 2 mg/ml Amp
(blue circles), and 3 mg/ml kanamycin (green diamonds), as well as
for no-drug controls (wild-type, gray squares; DrecA, black squares).
We used lower concentrations of Nor, Amp, and Kan in these experi-
ments to highlight the significant increase in killing in a recA knockout.
Figure 6. Proposed Model for Common
Mechanism of Killing by Bactericidal
Antibiotics
The primary drug-target interactions (amino-
glycoside with the ribosome, quinolone with
DNA gyrase, and b-lactam with penicillin-bind-
ing proteins) stimulate oxidation of NADH via
the electron transport chain that is dependent
upon the TCA cycle. Hyperactivation of the
electron transport chain stimulates superoxide
formation. Superoxide damages iron-sulfur
clusters, making ferrous iron available for oxi-
dation by the Fenton reaction. The Fenton re-
action leads to hydroxyl radical formation,
and the hydroxyl radicals damage DNA, pro-
teins, and lipids, which results in cell death.b-lactams, and aminoglycosides stimulate hydroxyl
radical formation via the Fenton reaction. Importantly,
both the iron chelator and a hydroxyl radical quencher
attenuate killing by bactericidal drugs, suggesting that
hydroxyl radicals contribute to bactericidal antibiotic-me-
diated cell death. While each of the bactericidal drugs
tested have different primary drug-target interactions,
we have shown they all converge on this free-radical-
based common pathway via a metabolic response involv-
ing the TCA cycle that induces rapid depletion of NADH.
We contend that this stimulates free-radical damage of
iron-sulfur clusters, leading to destabilization or leaching
of ferrous iron that participates in the Fenton reaction,
ultimately resulting in hydroxyl radical formation and cell
death (Figure 6). Using the iscS and tonB knockouts, we
showed that intracellular iron-sulfur clusters are an impor-
tant source of the iron required to stimulate Fenton-medi-
ated hydroxyl radical formation.
Interestingly, previous in vitro work has shown that, due
to their structures, bactericidal and bacteriostatic antibi-
otics can directly induce formation of reactive oxygenCspecies particularly in the presence of excess transition
metals such as copper or iron (Gutteridge et al., 1998), al-
though some of these reactions have turned out to be of
little likely consequence in vivo (Macomber et al., 2007).
In this study, we showed in vivo that bactericidal, but
not bacteriostatic, antibiotics stimulate the production of
hydroxyl radicals (Figure 1). In addition, the coordinated
metabolic and genetic changes we identified (Figure 3),
along with our gene expression results comparing bacte-
ricidal to bacteriostatic drug treatment (Table 1), suggest
that a specific series of intracellular events accompanying
the primary mode of action of bactericidal antibiotics are
responsible for the generation of lethal levels of hydroxyl
radicals (Figure 6). As noted above, we showed that all
bactericidal drug classes utilize internal iron from iron-
sulfur clusters to promote Fenton-mediated hydroxyl
radical formation and that these events appear to be
mediated by the TCA cycle and a transient depletion of
NADH.
It is somewhat surprising that current bactericidal anti-
biotics do not target the TCA cycle or respiratory chainell 130, 797–810, September 7, 2007 ª2007 Elsevier Inc. 807
more often, yet there is evidence that some mechanisms
of resistance to bactericidal drugs occur via these path-
ways. Aminoglycoside uptake and lethality are associated
with mistranslation, functional ubiquinones, a working
electron transport chain, and oxidative phosphorylation
(Taber et al., 1987). Among quinolones, one of the original
nalidixic acid-resistant strains was mapped to a loss of
isocitrate dehydrogenase, and a similar effect was
observed following removal of aconitase B (Gruer et al.,
1997; Helling and Kukora, 1971). Also, the efficacy of qui-
nolones in stationary phase can be enhanced by adding
oxygen to a stationary-phase culture (Morrissey and
Smith, 1994), and recent evidence suggests that meta-
bolic activity and oxygen tension are important indicators
of quinolone activity against biofilms (Walters et al., 2003).
This suggests that targeted inhibition of the TCA cycle or
electron transport chain may lead to loss of metabolic
activity and increased bactericidal drug resistance, rather
than a hyperactive metabolic state leading to an increase
in bactericidal drug sensitivity.
Other pathways besides the TCA cycle are likely
involved in regulating and responding to bactericidal anti-
biotic-mediated effects and deserve further study. For
example, further exploration of the posttranscriptional
relationship among iron, metabolism, and iron-sulfur
cluster-containing proteins (Hantke, 2001) is needed to
identify any posttranscriptional events not captured by
gene expression analysis that coordinate or trigger this
common cell death pathway. Importantly, our gene
expression results (Table 1) suggest that all bactericidal
antibiotics induce protective responses to reactive
oxygen species. There is a well-established regulatory
overlap between the genetic responses to oxidative stress
and antibiotic exposure: the multidrug efflux pump acrAB
is regulated by the superoxide-sensitive SoxR system,
and it has been suggested that the soxR-regulated genes
represent a coordinated response against antibiotics
(Greenberg et al., 1990). These response systems to reac-
tive oxygen species may represent pathways that can be
targeted to enhance the efficacy of current bactericidal
antibiotics. In addition, elucidation of the steps that occur
after the diverse bactericidal drug-target interactions but
before the step of NADH depletion is needed to further
our understanding of the common mechanism of killing
shown in Figure 6.
Antibacterial drug design has focused on blocking
essential cellular functions (Walsh, 2003). This has
yielded significant advances in antibacterial therapy;
however, the ever-increasing prevalence of antibiotic-
resistant strains has made it critical that we develop
novel, more effective means of killing bacteria. Our re-
sults indicate that targeting bacterial systems that re-
mediate hydroxyl radical damage, including proteins in-
volved in triggering the DNA damage response, e.g.,
RecA, is a viable means of potentiating all three major
classes of bactericidal drugs. Moreover, pathway anal-
yses and systems biology approaches may uncover
druggable targets for stimulating hydroxyl radical for-808 Cell 130, 797–810, September 7, 2007 ª2007 Elsevier Inc.mation, which could result in new classes of bacteri-
cidal antibiotics.
EXPERIMENTAL PROCEDURES
Media and Antibiotics
All experiments were performed in Luria-Bertani (LB) medium (Fisher
Scientific). For bactericidal drug experiments in E. coli, we used the an-
tibiotics ampicillin (Fisher Scientific), kanamycin (Fisher Scientific), and
norfloxacin (Sigma). For experiments in S. aureus, we used norfloxacin
and vancomycin (Teknova). For bacteriostatic drug experiments in
E. coli, we used the antibiotics rifamycin SV (MP Biomedicals), chlor-
amphenicol (Acros Organics), tetracycline (MP Biomedicals), erythro-
mycin (Sigma), and spectinomycin (MP Biomedicals). For experiments
in S. aureus, we used chloramphenicol.
Strains
All E. coli experiments were performed with MG1655 (ATCC 700926)-
derived strains (Table S4). The recA, iscS, and TCA-cycle knockouts
were constructed using P1 phage transduction and were derived
from an E. coli single-gene knockout library (Baba et al., 2006) (Table
S4). Positive P1 transductants were confirmed by acquisition of kana-
mycin resistance and PCR. Removal of the kanamycin-resistance cas-
sette was accomplished using the pcp20 plasmid (Datsenko andWan-
ner, 2000) (Table S4) and confirmed by PCR prior to experimentation.
For work with S. aureus, we used a S. aureus subspecies aureus Rose-
nbach (Table S4) strain obtained from ATCC (29740).
Growth Conditions
In our experiments, we compared the growth and survival of untreated
exponential-phase E. coli or S. aureus to cultures treated with the
above antibiotics at given concentrations. Briefly, cultures were grown
in 25 ml LB medium in 250 ml flasks and incubated at 37C and
300 rpm, and antibiotics were added at early exponential phase. To
ensure that light-induced redox cycling of antibiotics (Martin et al.,
1987; Umezawa et al., 1997) was not a confounding factor, all experi-
ments were performed in light-insulated shakers. For the iron chelation
experiments, 2,20-dipyridyl (500 mM, Sigma) was added simulta-
neously with antibiotics. For the hydroxyl radical quenching experi-
ments, thiourea (150 mM, Fluka) was added simultaneously with anti-
biotics. See Supplemental Data for more details.
DNA Damage Sensor and Hydroxyl Radical Experiments
Using Flow Cytometry
To monitor the occurrence of DNA damage, we employed an engi-
neered DNA damage sensor construct (see Supplemental Data). All
data were collected using a Becton Dickinson FACSCalibur flow cy-
tometer with a 488 nm argon laser and a 515–545 nm emission filter
(FL1) at low flow rate. At least 50,000 cells were collected for each
sample. The following photomultiplier tube (PMT) voltage settings
were used: E00 (FSC), 360 (SSC), and 700 (FL1). To detect hydroxyl
radical formation, we used the fluorescent reporter dye 30-(p-hydroxy-
phenyl) fluorescein (HPF, Invitrogen) at a concentration of 5 mM. The
following PMT voltage settings were used: E00 (FSC), 360 (SSC),
and 825 (FL1). Calibrite beads (Becton Dickinson) were used for instru-
ment calibration. Flow data were processed and analyzed with MAT-
LAB (The MathWorks). In all experiments, cells were grown as de-
scribed above. Samples were taken immediately before addition of
drug (time zero) and then every hour for 3 hr. At each time point, ap-
proximately 106 cells were collected, washed once, and resuspended
in filtered 13 PBS (pH 7.2) (Fisher Scientific) prior to measurement.
NAD+/NADH Extraction and NAD Cycling Assay
Dinucleotide extraction and the NAD cycling assay were performed as
previously described (Leonardo et al., 1996). See Supplemental Data
for more details.
Gene Expression Analysis
We compared the microarray-determined mRNA profiles (Affymetrix
E. coli Antisense2 genome arrays) of wild-type E. coli cultures in re-
sponse to bactericidal antibiotic treatment (250 ng/ml norfloxacin,
5 mg/ml ampicillin, and 5 mg/ml kanamycin) to that of bacteriostatic
antibiotic treatment (400 mg/ml spectinomycin) or untreated cells. For
all experiments, overnight cultures were diluted 1:500 into 250 ml LB
medium in 1 l flasks for collection of total RNA. Early exponential-
phase cultures were split (50 ml LB medium into 53 250 ml flasks),
and antibiotics were added as described above. Samples for microar-
ray analysis were taken immediately before treatment (time zero) and
then at 30, 60, and 120 min posttreatment. RNA collection and micro-
array processing are described further in the Supplemental Data.
The resulting microarray *.CEL files were combined with *.CEL files
from arrays that comprise the M3D compendium (Faith et al., 2007)
(http://m3d.bu.edu; E_coli_v3_Build_3) and RMA normalized (Bolstad
et al., 2003) with RMAExpress, for a total of 524 RMA-normalized
E. coli expression arrays. Each gene’s standard deviation of expres-
sion, s, was calculated and used to construct the z scale difference
between that gene’s normalized expression in a given experimental
condition (bactericidal drug treatment) versus a control (bacteriostatic
drug treatment):
Dzexp =
Xexp  Xctl
s
:
This allowed us to measure each gene’s change in expression for
a given experiment in units of standard deviation, a form of the z test.
For each time point in each bactericidal experiment set (norfloxacin,
ampicillin, and kanamycin), we converted Dz scores to p values and
chose significantly up- and downregulated genes by selecting those
with a q value < 0.05 (false discovery rate) (Storey and Tibshirani,
2003). We merged the resultant gene lists across all time points (set
union) to obtain a coarse profile of the difference in expression be-
tween a given bactericidal drug and spectinomycin. Finally, we deter-
mined the common set of all genes that were up- or downregulated by
bactericidal concentrations of norfloxacin, kanamycin, and ampicillin
with respect to spectinomycin (three-way set intersect). For additional
pathway-level insights, we performed Gene Ontology-based enrich-
ment (Ashburner et al., 2000; Camon et al., 2004) of the up- and down-
regulated gene lists using GO::TermFinder (Boyle et al., 2004), requir-
ing pathway enrichment q values to be <0.05 and setting the p value
estimation mode to bootstrapping.
Supplemental Data
Supplemental Data include Supplemental Discussion, Supplemental
Experimental Procedures, Supplemental References, ten figures,
and four tables and can be found with this article online at http://
www.cell.com/cgi/content/full/130/5/797/DC1/.
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